How do you approach isolated CNS recurrence in previously treated neuroblastoma?  

Some emerging data of improved up front therapy shifting recurrence to CNS as sanctuary site, is focal RT approach (i.e. SRS) reasonable or is CSI a stronger consideration?



Answer from: Radiation Oncologist at Academic Institution